Skip to content

Controlled Fluid Resuscitation Strategy in Sepsis Patient

Controlled Fluid Resuscitation Strategy in Sepsis Patient: a mulitcentral randomized-control clinical study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011928
Enrollment
Unknown
Registered
2017-07-10
Start date
2017-08-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Group 1:Regular fluid therapy
Group 2:Restricted fluid resuscitation group

Sponsors

Ruijin Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. sepsis patients in accordance with the Sepsis 3.0 definition 1) Confirm or suspect the presence of focal infection; 2) SOFA increase =1 compared to the baseline due to infection); 3) the first blood lactate in our hospital is = 2mmol/L or MAP<65mmHg(or SBP<90) after 20ml/kg fluid bolus; or vasoactive drugs were required to maintain MAP greater than or equal to 65mmHg; 2. Aged 18-85 years; 3. Sign informed consent form.

Exclusion criteria

Exclusion criteria: 1. pregnancy, preparing for pregnancy or breastfeeding ; 2. with co-morbidity such as AE-COPD, stroke, lung edema, acute coronary syndrome; 3. with contra-indication of CVC (central venous catheter) placement; 4. Active gastrointestinal bleeding; 5. seizure; 6. poisoning; 7. trauma, major burn; 8. uncured malignant tumor; 9. emergency operation; 10. systemic autoimmune disease or immunosuppression (solid organ or bone marrow transplantation, AIDS, long-term use of immunosuppressive agents or hormones); 11. have a desire to cease or desist from maintaining life in a human manner (treatment abandoning); 12. an estimated survival time of <28 days for the underlying disease or terminal state; 13. death within 24 hours; 14. cardiopulmonary resuscitation was performed within 72 hours and nerve function was not restored; 15. the source of infection cannot be removed, such as surgical intervention or drainage.

Design outcomes

Primary

MeasureTime frame
mortality in 28 days;

Countries

China

Contacts

Public ContactErzhen Chen

Ruijin Hospital

chenerzhen@hotmail.com+86 18917762828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026